Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti- lymphocyte globulin treatment for acute rejection  Michael J. Dickenmann,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cavallo  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Clinical Microbiology and Infection
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz 
Clinical Microbiology and Infection
M. Nørgaard, H. Larsson, G. Pedersen, H.C. Schønheyder, H.T. Sørensen 
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Cutaneous sporotrichosis: the old iodide treatment remains effective
Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain  J.-M. Aguado, C. Lumbreras, D.
Vector control: a cornerstone in the malaria elimination campaign
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales 
Training for the infectious diseases speciality in Norway
Retrospective study of CMV retinitis in patients with AIDS
Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever?  S. Edouard, A. Michel-Lepage, D. Raoult 
B. Gordts  Clinical Microbiology and Infection 
Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated.
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
Acute schistosomiasis, a diagnostic and therapeutic challenge
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital  R. Herruzo, F.
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Current experience in treating invasive zygomycosis with posaconazole
Reducing antibiotic use in influenza: challenges and rewards
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Leishmaniasis in immunosuppressed individuals
Tuberculosis in HIV-infected patients: a comprehensive review
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
B.A. Cunha  Clinical Microbiology and Infection 
N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Community-acquired acute bacterial meningitis in the elderly in Turkey
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti- lymphocyte globulin treatment for acute rejection  Michael J. Dickenmann, Kairat Kabulbayev, Jürg Steiger, Gieri Cathomas, Pierre Reusser, Michael Tamm  Clinical Microbiology and Infection  Volume 10, Issue 4, Pages 337-339 (April 2004) DOI: 10.1111/j.1198-743X.2004.00827.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Cumulative number of patients developing CMV infection or CMV disease within 6 months of rejection therapy (51 patients at risk). Clinical Microbiology and Infection 2004 10, 337-339DOI: (10.1111/j.1198-743X.2004.00827.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.